Literature DB >> 22905695

New challenges and opportunities for industrial biotechnology.

Guo-Qiang Chen1.   

Abstract

Industrial biotechnology has not developed as fast as expected due to some challenges including the emergences of alternative energy sources, especially shale gas, natural gas hydrate (or gas hydrate) and sand oil et al. The weaknesses of microbial or enzymatic processes compared with the chemical processing also make industrial biotech products less competitive with the chemical ones. However, many opportunities are still there if industrial biotech processes can be as similar as the chemical ones. Taking advantages of the molecular biology and synthetic biology methods as well as changing process patterns, we can develop bioprocesses as competitive as chemical ones, these including the minimized cells, open and continuous fermentation processes et al.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22905695      PMCID: PMC3520750          DOI: 10.1186/1475-2859-11-111

Source DB:  PubMed          Journal:  Microb Cell Fact        ISSN: 1475-2859            Impact factor:   5.328


The commercialization of industrial biotechnology is not as fast as we expected. Originally, we believe that production of bulk chemicals including biofuels, polymeric materials and chemical agents using microorganisms or enzymes will provide low cost, environmentally friendly products to partially replace petro-chemicals products [1]. However, this looks not so easy to materialize due to the facts that: 1. Petroleum does not rise in price too much after 2008 financial crisis, other alternative energy sources, especially shale gas, natural gas hydrate (or gas hydrate) and sand oil, have been discovered in large amount and their exploitations are increasingly moving toward a very competitive price; 2. The exhaustion of petroleum seems to be a remote reality 3. Agriculture raw materials for bioprocessing are becoming increasingly costly 4. Low cost raw material cellulose can not be easily used for microbial processes at least for the next 5–10 years 5. Bioprocessing is still not as effective as chemical processing, resulting in high cost of bio-products (Table 1)
Table 1

Comparison of industrial biotechnology and chemical technology

ItemsIndustrial biotechnologyChemical technology
Reaction Time
Slow: production takes days
Fast: production takes hours
Substrates
Agricultural products
Petroleum or its derivatives
Conversion of substrates to products
Low: e.g. PHB/glucose ≈ 33 wt% PHA/fatty acids ≈ 60 wt%
High: e.g. Polyethylene/ethylene ≈ 100%
Medium
Water
Mostly organic solvents
Consumption of water
A lot
Less
Reaction conditions
30-40°C, normal pressure
Generally >100°C, High Pressures
Product concentration
Low: Several mg to 100 g/L
Very high
Product recovery cost
Very high
Low to medium
Processing
Normally discontinuous one
Can be continuous
Sterilization
Necessary
No need
Production facility cost
Very high
Low to high (explosive proof)
Waste waterNot toxic, easier to treatGenerally toxic, difficult to treat
6. Bioprocessing that requires large amount of fresh water has had increasing concerns in many water shortage areas 7. The chemical industry is also evolving competitive in various ways including environmentally friendliness, the use of renewable resources (biomass) for making chemicals that are normally derived from petro-chemicals 8. The rapid development of C1 chemical engineering products 9. Large amount of funding is not more directed to industrial biotechnology. Comparison of industrial biotechnology and chemical technology Taking the example of polyhydroxyalkanoates (PHA), a biopolyester family that has been exploited to become an industrial value chain [2-4], PHA has not been able to commercially produce in large scale due to the difficulty to lower the production cost especially for their applications as bioplastics that are considered as biodegradable and bio-based despite the possibility of using CO2 as substrate [5]. To successfully commercialize PHA, we must keep working hard on the “high volume and low price” strategy by developing better PHA production strains and cost competitive processes. While for some special applications, “low volumes and high price” can be applied, such as products to be used for biomedical purposes, specialty polymers [6,7], chiral monomers, drug development and special applications et al. [8,9]. And this is generally true in order to survive this competitive environment for industrial biotechnology, it must be competitive with the chemical industry. Let’s see what we can do to make this happen. In addition, it is also important to be able to develop processes that combined the advantages of chemical industry to supplement the weaknesses of industrial biotechnology (Table 1). The newly emerging synthetic biology approaches may offer some clues for developing competitive technology for industrial biotechnology to produce “high volume and low price” products (Table 2). At the same time, bio-processing should try to become as similar as the chemical industry, including the need to develop continuous and open fermentation processes for e.g. making biofuels and PHA bioplastics [10-12]. Also, from now and toward a distant future, foods are still important for feeding the world population, the development of bioprocesses based on kitchen waste or activated sludge as substrates may also be an important option for a competitive industrial biotechnology (Table 2).
Table 2

Problems to be solved for making industrial biotechnology competitive to chemical technology

ProblemsWeakness of Industrial biotechnologyPossible solutions
Microorganisms grow too slow
Slow: production takes days
Minimizing the microbial cells
Microbes can not use mixed substrates
Agricultural products are mostly mixed substrates
Assembling pathways that can metabolize mixed substrates
Low conversion of substrates to products
Cell metabolism turn substrates into CO2, H2O & byproducts
Removing unnecessary pathways consuming substrates
High Consumption on fresh H2O
Fresh H2O as medium et al.
Utilization of sea water for cell growth
Microbial cells grow to very low density
Product concentration low: Several mg to 100 g/L
Minimizing oxygen demand for aerobic cells & reducing Quorum sensing effects
Discontinuous processing
Contamination concerns
Developing continuous process
Sterilization costs high
High pressed steam
Contamination resisting strains grown in open systems
High energy demand for intensive aeration
Aerobic microorganisms need a lot of oxygen for growth
Developing anaerobic bioprocesses
Difficulty to control the bio-processes
Complicated cellular metabolisms
Artificial cells that contain only necessary metabolic pathways
One product by one microbial organism
Different organism has different strength.
Development of a platform organism for many products
Organisms consume food related products
Food for Fuels (Chemicals)
Kitchen wastes or activated sludge as substrates
Production facility costlyCostly materials and sensorsThe use of carbon steel facilities et al.
Problems to be solved for making industrial biotechnology competitive to chemical technology Combination of bio- and chemical processes can offer a lot of advantages including bio-based (CO2 reduction) and fast reaction. Typical example includes the bio-production of lactic acid from anaerobic fermentation that is very effective and has only one single lactic acid product, and chemical polymerization of lactide to polylactide (PLA), a biodegradable green plastic [2,13]. The PLA story is a successful combination of bio- and chemical advantages. Others like succinic acid and 1,4-butanol bio-production and their copolymerization are under intensive R&D [2,13]. However, at the end, commercial successes have to be dependent on economy.

Competing interests

The author declares that he has no competing interests.
  13 in total

Review 1.  A microbial polyhydroxyalkanoates (PHA) based bio- and materials industry.

Authors:  Guo-Qiang Chen
Journal:  Chem Soc Rev       Date:  2009-05-08       Impact factor: 54.564

2.  Chemical biotechnology in progress.

Authors:  Guo-Qiang Chen; Romas Kazlauskas
Journal:  Curr Opin Biotechnol       Date:  2011-08-20       Impact factor: 9.740

Review 3.  Polyhydroxyalkanoates as a source of chemicals, polymers, and biofuels.

Authors:  Xue Gao; Jin-Chun Chen; Qiong Wu; Guo-Qiang Chen
Journal:  Curr Opin Biotechnol       Date:  2011-06-24       Impact factor: 9.740

4.  Unsterile and continuous production of polyhydroxybutyrate by Halomonas TD01.

Authors:  Dan Tan; Yuan-Sheng Xue; Gulsimay Aibaidula; Guo-Qiang Chen
Journal:  Bioresour Technol       Date:  2011-05-30       Impact factor: 9.642

Review 5.  Microbial production of building block chemicals and polymers.

Authors:  Jeong Wook Lee; Hyun Uk Kim; Sol Choi; Jongho Yi; Sang Yup Lee
Journal:  Curr Opin Biotechnol       Date:  2011-03-17       Impact factor: 9.740

6.  Microbial polyhydroxyalkanote synthesis repression protein PhaR as an affinity tag for recombinant protein purification.

Authors:  Shuang Zhang; Zhi Hui Wang; Guo Qiang Chen
Journal:  Microb Cell Fact       Date:  2010-05-10       Impact factor: 5.328

7.  Application of (R)-3-hydroxyalkanoate methyl esters derived from microbial polyhydroxyalkanoates as novel biofuels.

Authors:  Xiaojun Zhang; Rongcong Luo; Zhen Wang; Yuan Deng; Guo-Qiang Chen
Journal:  Biomacromolecules       Date:  2009-04-13       Impact factor: 6.988

8.  Enrichment of a mixed bacterial culture with a high polyhydroxyalkanoate storage capacity.

Authors:  Katja Johnson; Yang Jiang; Robbert Kleerebezem; Gerard Muyzer; Mark C M van Loosdrecht
Journal:  Biomacromolecules       Date:  2009-04-13       Impact factor: 6.988

9.  Hyperproduction of poly(4-hydroxybutyrate) from glucose by recombinant Escherichia coli.

Authors:  Xiao-Yun Zhou; Xiao-Xi Yuan; Zhen-Yu Shi; De-Chuang Meng; Wen-Jun Jiang; Lin-Ping Wu; Jin-Chun Chen; Guo-Qiang Chen
Journal:  Microb Cell Fact       Date:  2012-05-02       Impact factor: 5.328

10.  A transferable heterogeneous two-hybrid system in Escherichia coli based on polyhydroxyalkanoates synthesis regulatory protein PhaR.

Authors:  Zhi-Hui Wang; Ping Ma; Jiong Chen; Jing Zhang; Chong-Bo Chen; Guo-Qiang Chen
Journal:  Microb Cell Fact       Date:  2011-04-09       Impact factor: 5.328

View more
  17 in total

Review 1.  Co-culture systems and technologies: taking synthetic biology to the next level.

Authors:  Lisa Goers; Paul Freemont; Karen M Polizzi
Journal:  J R Soc Interface       Date:  2014-07-06       Impact factor: 4.118

2.  Phototrophic Lactate Utilization by Rhodopseudomonas palustris Is Stimulated by Coutilization with Additional Substrates.

Authors:  Alekhya Govindaraju; James B McKinlay; Breah LaSarre
Journal:  Appl Environ Microbiol       Date:  2019-05-16       Impact factor: 4.792

3.  Differences in barriers for controlled learning about safety between biotechnology and chemistry.

Authors:  Britte Bouchaut; Frank Hollmann; Lotte Asveld
Journal:  Nat Commun       Date:  2022-07-14       Impact factor: 17.694

4.  Systems metabolic engineering, industrial biotechnology and microbial cell factories.

Authors:  Sang Yup Lee; Diethard Mattanovich; Antonio Villaverde
Journal:  Microb Cell Fact       Date:  2012-12-11       Impact factor: 5.328

5.  Structural and functional features of self-assembling protein nanoparticles produced in endotoxin-free Escherichia coli.

Authors:  Fabián Rueda; María Virtudes Céspedes; Alejandro Sánchez-Chardi; Joaquin Seras-Franzoso; Mireia Pesarrodona; Neus Ferrer-Miralles; Esther Vázquez; Ursula Rinas; Ugutz Unzueta; Uwe Mamat; Ramón Mangues; Elena García-Fruitós; Antonio Villaverde
Journal:  Microb Cell Fact       Date:  2016-04-08       Impact factor: 5.328

Review 6.  Models in the Research Process of Psoriasis.

Authors:  Katarzyna Bocheńska; Elwira Smolińska; Marta Moskot; Joanna Jakóbkiewicz-Banecka; Magdalena Gabig-Cimińska
Journal:  Int J Mol Sci       Date:  2017-11-24       Impact factor: 5.923

Review 7.  13C-Metabolic Flux Analysis: An Accurate Approach to Demystify Microbial Metabolism for Biochemical Production.

Authors:  Weihua Guo; Jiayuan Sheng; Xueyang Feng
Journal:  Bioengineering (Basel)       Date:  2015-12-25

8.  An efficient graph theory based method to identify every minimal reaction set in a metabolic network.

Authors:  Sudhakar Jonnalagadda; Rajagopalan Srinivasan
Journal:  BMC Syst Biol       Date:  2014-03-04

Review 9.  Elucidation of intrinsic biosynthesis yields using 13C-based metabolism analysis.

Authors:  Arul M Varman; Lian He; Le You; Whitney Hollinshead; Yinjie J Tang
Journal:  Microb Cell Fact       Date:  2014-03-19       Impact factor: 5.328

10.  Bacterial cell factories for recombinant protein production; expanding the catalogue.

Authors:  Neus Ferrer-Miralles; Antonio Villaverde
Journal:  Microb Cell Fact       Date:  2013-11-18       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.